Enrique Baca

469 total citations
28 papers, 294 citations indexed

About

Enrique Baca is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Enrique Baca has authored 28 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 7 papers in Clinical Psychology. Recurrent topics in Enrique Baca's work include Treatment of Major Depression (7 papers), Schizophrenia research and treatment (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Enrique Baca is often cited by papers focused on Treatment of Major Depression (7 papers), Schizophrenia research and treatment (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Enrique Baca collaborates with scholars based in Spain, United Kingdom and Belgium. Enrique Baca's co-authors include Margarida García-García, M.Á. Ruiz, Miquel Roca, Alberto Fernández-Liria, Jesús Saiz Galdós, L. Agüera, Ángel Gil, Antonio R. Porras, Enrique Baca‐García and Rita Prieto and has published in prestigious journals such as The Journal of Clinical Psychiatry, Progress in Neuro-Psychopharmacology and Biological Psychiatry and International Journal of Geriatric Psychiatry.

In The Last Decade

Enrique Baca

27 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enrique Baca Spain 8 97 86 82 79 50 28 294
Anita Volkers Netherlands 7 115 1.2× 53 0.6× 87 1.1× 99 1.3× 48 1.0× 8 353
Marta M. Maslej Canada 13 90 0.9× 66 0.8× 70 0.9× 61 0.8× 120 2.4× 30 388
Tirril Harris United Kingdom 8 74 0.8× 39 0.5× 83 1.0× 75 0.9× 33 0.7× 11 237
Michael Tedeschi Australia 5 138 1.4× 116 1.3× 88 1.1× 125 1.6× 64 1.3× 13 358
Renske C. Bosman Netherlands 9 45 0.5× 67 0.8× 123 1.5× 104 1.3× 117 2.3× 11 329
Mascha C. ten Doesschate Netherlands 6 116 1.2× 154 1.8× 92 1.1× 83 1.1× 145 2.9× 7 352
Ymkje Anna de Vries Netherlands 10 59 0.6× 64 0.7× 73 0.9× 26 0.3× 74 1.5× 19 311
Barbara J. van Zwieten Netherlands 12 196 2.0× 156 1.8× 117 1.4× 41 0.5× 58 1.2× 13 372
Emanuela Trogu Italy 13 161 1.7× 111 1.3× 114 1.4× 35 0.4× 60 1.2× 19 545
John M. Plewes United States 10 134 1.4× 169 2.0× 110 1.3× 92 1.2× 122 2.4× 20 384

Countries citing papers authored by Enrique Baca

Since Specialization
Citations

This map shows the geographic impact of Enrique Baca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Baca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Baca more than expected).

Fields of papers citing papers by Enrique Baca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Baca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Baca. The network helps show where Enrique Baca may publish in the future.

Co-authorship network of co-authors of Enrique Baca

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Baca. A scholar is included among the top collaborators of Enrique Baca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Baca. Enrique Baca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Treur, M., Enrique Baca, Julio Bobes, et al.. (2012). The cost-effectiveness of paliperidone extended release in Spain. Journal of Medical Economics. 15(sup1). 26–34. 16 indexed citations
2.
Ciudad, Antonio, Enric Álvarez, Miquel Roca, et al.. (2011). Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up. The Journal of Clinical Psychiatry. 73(2). 185–191. 29 indexed citations
3.
Baca, Enrique, et al.. (2010). Historical perspectives of the role of Spain and Portugal in today's status of psychiatry and mental health in Latin America. International Review of Psychiatry. 22(4). 311–316. 4 indexed citations
4.
Rubio-Terrés, Carlos, et al.. (2010). PMH36 ECONOMIC EVALUATION ANALYSIS IN THE TREATMENT OF BIPOLAR DISORDER WITH ARIPIPRAZOLE AND OTHER ATYPICAL ANTIPSYCHOTIC DRUGS IN SPAIN. Value in Health. 13(7). A452–A452. 2 indexed citations
5.
Bousoño, Manuel, et al.. (2008). Complicaciones de la depresión a largo plazo. Actas Españolas de Psiquiatría. 36(2). 44–52. 1 indexed citations
6.
Baca, Enrique, et al.. (2008). [Diagnostic errors and temporal stability in bipolar disorder].. PubMed. 36(4). 205–9. 11 indexed citations
7.
Roca, Miquel, et al.. (2007). [Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].. PubMed. 36(2). 82–9. 2 indexed citations
8.
Rodríguez‐Artalejo, Fernando, Enrique Baca, Juan Francisco Merino-Torres, et al.. (2006). Valoración y control del riesgo metabólico y cardiovascular en los pacientes con esquizofrenia. Medicina Clínica. 127(14). 542–548. 5 indexed citations
9.
Baca, Enrique, et al.. (2006). Venlafaxine extended-release in patients older than 80 years with depressive syndrome. International Journal of Geriatric Psychiatry. 21(4). 337–343. 9 indexed citations
10.
Carballo, Juan J., María A. Oquendo, Lucas Giner, et al.. (2006). Demographic and clinical features of adolescents and young adults with alcohol-related disorders admitted to the Psychiatric Emergency Room. International Journal of Adolescent Medicine and Health. 18(1). 87–96. 4 indexed citations
11.
Baca, Enrique, et al.. (2005). Ziprasidone: from pharmacology to the clinical practice. One year of experience.. PubMed. 33(5). 311–24. 5 indexed citations
12.
13.
Baca, Enrique, Enrique Baca‐García, M. Mercedes Pérez-Rodríguez, & María Luisa Cabañas. (2004). Short and Long-Term Effects of Terrorist Attacks in Spain. Journal of Aggression Maltreatment & Trauma. 9(1-2). 157–170. 6 indexed citations
14.
15.
Giner, J, et al.. (2004). [Impact of olanzapine on quality of life of patients with schizophrenia: one-year follow-up with the Seville Quality of Life Questionnaire].. PubMed. 32(1). 1–7. 5 indexed citations
16.
Baca, Enrique, et al.. (2003). Sertraline is more effective than imipramine in the treatment of non-melancholic depression:. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(3). 493–500. 10 indexed citations
17.
Baca, Enrique, et al.. (2003). Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(1). 57–65. 89 indexed citations
18.
Baca‐García, Enrique, et al.. (2000). Nuevas perspectivas en formación médica continuada: el empleo de las nuevas tecnologías de telecomunicaciones. Medicina Clínica. 114(18). 704–711. 3 indexed citations
19.
Ruiz, M.Á. & Enrique Baca. (1993). Design and validation of the "Quality of Life Questionnaire" ("Cuestionario de Calidad de Vida", CCV): A generic health-related perceived quality of life instrument.. European Journal of Psychological Assessment. 17 indexed citations
20.
Herrero, Marta & Enrique Baca. (1990). Specific Treatment Demand as a Definitely Trait of a Typology in Heroin Addicts: Differential Profile of Two Subpopulations. International Journal of the Addictions. 25(1). 65–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita Volkers Breakdown of academic impact, for papers by Marta M. Maslej Breakdown of academic impact, for papers by Tirril Harris Breakdown of academic impact, for papers by Michael Tedeschi Breakdown of academic impact, for papers by Renske C. Bosman Breakdown of academic impact, for papers by Mascha C. ten Doesschate Breakdown of academic impact, for papers by Ymkje Anna de Vries Breakdown of academic impact, for papers by Barbara J. van Zwieten Breakdown of academic impact, for papers by Emanuela Trogu Breakdown of academic impact, for papers by John M. Plewes
Rankless by CCL
2026